And, to avoid structural liabilities, Fusion Antibodies utilizes state-of-the-art three-dimensional (3D) protein structural modeling tools, rather than relying on guesswork for epitope prediction.
Lipid-tagged antibodies: Bacterial expression and characterization of a lipoprotein-single-chain antibody fusion protein. Protein Eng. 6, 449–454 ( 1993).
Fusion Antibodies plc (LON:FAB – Get Free Report) shares dropped 1.2% on Friday . The company traded as low as GBX 4.20 ($0.05) and last traded at GBX 4.25 ($0.05). Approximately 116,900 shares were ...
Antibody-drug conjugates (ADCs) can be described as highly targeted biopharmaceutical drugs that integrate monoclonal antibodies specific to surface antigens and highly potent anti-cancer agents ...
Researchers from Elpiscience Biopharmaceuticals Inc. discussed the discovery and preclinical characterization of a novel NKG2A antibody-IL-2 mutant fusion protein – ES-015.129 – being developed as ...
Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases ...
WuXia™ RidGS ensures cell line stability for mAbs, as well as for various other therapeutic modalities, including bispecific antibodies, Fc-fusion proteins, and recombinant proteins. The quality ...